PI3K inhibitor BEZ235, Purity ≥98%

Cat. No.: X24-05-ZQ005

PI3K inhibitor BEZ235, Purity ≥98%

Synonym: 915019-65-7; NVP-BEZ235; Dactolisib; PI3K inhibitor

  • CAS Number: 915019-65-7
  • Compound CID: 11977753
Product Size
25 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
BEZ235, soluble in DMSO and warmed ethanol and insoluble in water, is a potent compound that inhibits PI3 kinase activity. It targets mTOR (p70S6K), p110γ, Akt1/PKBα, ATR, B-Raf (V599E), c-Abl, c-Met, c-Src, CDK1, EGFR/ErbB1, and EphB4.
Molecular Weight
469.6
Molecular Formula
C30H23N5O
Targets
mTOR (p70S6K): 6 nM; p110γ: 5 nM; Akt1/PKBα: >10 μM; ATR: 21 nM; B-Raf (V599E): >10 μM; c-Abl: >10 μM; c-Met: >10 μM; c-Src: >10 μM; CDK1: >10 μM; EGFR/ErbB1: >8.5 μM; EphB4: >10 μM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: <1 mg/mL; Water: Insoluble; Warmed ethanol: 16 mg/mL (34.07 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
BEZ235 can be used to investigate its dual PI3K/mTOR inhibition for potential anticancer treatment.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.